Therefore, we concluded that RSL-induced ferroptosis may promote the antitumor effect of anti-PD-1 treatment by enhancing the repertoire and frequency of tumor neoantigen-specific IFN-γ+ CD8+ T cells. This evidence concerns the gene PDCD1 and neoplasm.